By Leika Kihara TOKYO (Reuters) – Asia’s factory activity contracted in January as the boost from China’s COVID reopening had yet to offset headwinds from slowing U.S. and European growth,…
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Category:
News
-
-
-
-
-
-
-
-
By Maki Shiraki and Gilles Guillaume TOKYO/PARIS (Reuters) -Nissan Motor Co and Renault SA agreed on Monday to a sweeping remake of their two-decade-old automaking alliance that will put them…
-
-
By Mehnaz Yasmin (Reuters) -Visa Inc’s revenue growth continued to wind back to pre-pandemic levels in the first quarter as the post-lockdown travel craze ebbed and consumer spending slowed in…
-
By Michael Erman and Leroy Leo (Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19…
-
Newer Posts